A detailed history of Everence Capital Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 2,790 shares of BIIB stock, worth $486,576. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,790
Previous 5,000 44.2%
Holding current value
$486,576
Previous $1.07 Million 49.63%
% of portfolio
0.03%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$189.07 - $236.8 $417,844 - $523,328
-2,210 Reduced 44.2%
2,790 $541,000
Q4 2023

Jan 30, 2024

BUY
$222.59 - $267.94 $233,719 - $281,337
1,050 Added 26.58%
5,000 $1.29 Million
Q4 2022

Jan 31, 2023

BUY
$252.44 - $306.72 $22,719 - $27,604
90 Added 2.33%
3,950 $1.09 Million
Q2 2022

Jul 26, 2022

SELL
$187.54 - $223.02 $275,683 - $327,839
-1,470 Reduced 27.58%
3,860 $787,000
Q1 2022

Apr 11, 2022

SELL
$193.77 - $244.14 $352,661 - $444,334
-1,820 Reduced 25.45%
5,330 $1.12 Million
Q4 2021

Jan 28, 2022

BUY
$223.92 - $287.77 $799,394 - $1.03 Million
3,570 Added 99.72%
7,150 $1.72 Million
Q4 2020

Feb 01, 2021

SELL
$236.26 - $355.63 $54,339 - $81,794
-230 Reduced 6.04%
3,580 $877,000
Q4 2019

Jan 28, 2020

SELL
$220.06 - $304.07 $142,158 - $196,429
-646 Reduced 14.5%
3,810 $1.13 Million
Q1 2019

May 06, 2019

SELL
$216.71 - $338.96 $45,942 - $71,859
-212 Reduced 4.54%
4,456 $1.05 Million
Q4 2017

Feb 02, 2018

BUY
$307.64 - $344.58 $174,124 - $195,032
566 Added 13.8%
4,668 $1.49 Million
Q3 2017

Oct 31, 2017

BUY
$281.15 - $329.69 $1.15 Million - $1.35 Million
4,102
4,102 $1.28 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.